Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
ACS Med Chem Lett
2011 Apr 14;24:307-312. doi: 10.1021/ml100297w.
Show Gene links
Show Anatomy links
Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus.
Wang J
,
Ma C
,
Balannik V
,
Pinto LH
,
Lamb RA
,
Degrado WF
.
???displayArticle.abstract???
Inhibitors targeting the influenza A virus M2 (A/M2) proton channel, have lost their effectiveness due to widespread resistance. As a first step in the development of new inhibitors that address this problem, we have screened several focused collections of small molecules using two electrode voltage patch clamp assays (TEVC) on Xenopus laevis Oocyte. Diverse head groups and scaffolds of A/M2 inhibitors have been explored. It has been found that not only amine, but also hydroxyl, aminooxyl, guanidine and amidine compounds are active against the A/M2 proton channel. Moreover, the channel is able to accommodate a wide range of structural variation in the apolar scaffold. This study offers information to guide the next generation of A/M2 proton channel inhibitor design.
Acharya,
Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus.
2010, Pubmed,
Xenbase
Acharya,
Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus.
2010,
Pubmed
,
Xenbase
Balannik,
Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.
2009,
Pubmed
,
Xenbase
Balannik,
The oligomeric state of the active BM2 ion channel protein of influenza B virus.
2008,
Pubmed
Bright,
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.
2005,
Pubmed
Cady,
Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers.
2010,
Pubmed
Chizhmakov,
Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells.
1996,
Pubmed
DAVIES,
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).
1964,
Pubmed
De Clercq,
Antiviral agents active against influenza A viruses.
2006,
Pubmed
Deyde,
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
2007,
Pubmed
Du,
Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
2010,
Pubmed
Hu,
Identification of hits as matrix-2 protein inhibitors through the focused screening of a small primary amine library.
2010,
Pubmed
Kolocouris,
Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues.
2008,
Pubmed
Lagoja,
Anti-influenza virus agents: synthesis and mode of action.
2008,
Pubmed
Martin,
Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.
1991,
Pubmed
Pinto,
Influenza virus M2 protein has ion channel activity.
1992,
Pubmed
,
Xenbase
Saito,
Frequency of amantadine-resistant influenza A viruses during two seasons featuring cocirculation of H1N1 and H3N2.
2003,
Pubmed
Schnell,
Structure and mechanism of the M2 proton channel of influenza A virus.
2008,
Pubmed
Stouffer,
Structural basis for the function and inhibition of an influenza virus proton channel.
2008,
Pubmed
Takeda,
Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
2002,
Pubmed
Tataridis,
Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus A.
2007,
Pubmed
Wang,
Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.
1993,
Pubmed
,
Xenbase
Wang,
Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus.
2009,
Pubmed
,
Xenbase
Zoidis,
Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines.
2010,
Pubmed
